The Impact of Stone Composition on Treatment Strategies for Patients with Urolithiasis: A Narrative Review

Urolithiasis is a multifactorial condition where stone composition is critical in guiding treatment and prevention strategies. Advanced diagnostic techniques, such as infrared spectroscopy, provide precise stone analysis, enabling clinicians to tailor interventions based on specific stone types and associated metabolic abnormalities. Calcium oxalate monohydrate stones often require invasive approaches like percutaneous nephrolithotomy, while uric acid responds well to dissolution therapy. Cystine stones, linked to genetic cystinuria, necessitate lifelong management, including aggressive hydration, urinary alkalinization, and pharmacological treatments such as tiopronin. Stone composition significantly influences treatment decisions and recurrence prevention in urolithiasis. Integrating detailed compositional analysis into clinical practice enables personalized interventions, improving outcomes and reducing recurrence rates. Future research should focus on refining diagnostic techniques and exploring novel therapies to address the metabolic and environmental contributors to stone formation. Adopting a multidisciplinary, patient-centered approach is essential for advancing the management of urolithiasis.